Renaissance Technologies’s MediciNova MNOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $260K | Sell |
189,900
-6,900
| -4% | -$10.5K | ﹤0.01% | 2848 |
|
|
2025
Q4 | $258K | Buy |
196,800
+4,300
| +2% | +$5.93K | ﹤0.01% | 2818 |
|
|
2025
Q3 | $244K | Buy |
192,500
+13,800
| +8% | +$17.8K | ﹤0.01% | 3081 |
|
|
2025
Q2 | $234K | Sell |
178,700
-3,000
| -2% | -$4.2K | ﹤0.01% | 3126 |
|
|
2025
Q1 | $265K | Buy |
181,700
+400
| +0.2% | +$707 | ﹤0.01% | 2972 |
|
|
2024
Q4 | $381K | Sell |
181,300
-5,300
| -3% | -$10.3K | ﹤0.01% | 2965 |
|
|
2024
Q3 | $392K | Sell |
186,600
-23,400
| -11% | -$34.6K | ﹤0.01% | 2885 |
|
|
2024
Q2 | $302K | Sell |
210,000
-20,400
| -9% | -$28.6K | ﹤0.01% | 2904 |
|
|
2024
Q1 | $334K | Buy |
230,400
+56,300
| +32% | +$79.9K | ﹤0.01% | 3046 |
|
|
2023
Q4 | $261K | Buy |
174,100
+24,500
| +16% | +$44.3K | ﹤0.01% | 3038 |
|
|
2023
Q3 | $313K | Buy |
149,600
+2,700
| +2% | +$6.28K | ﹤0.01% | 2910 |
|
|
2023
Q2 | $338K | Buy |
146,900
+2,500
| +2% | +$5.51K | ﹤0.01% | 3078 |
|
|
2023
Q1 | $312K | Buy |
144,400
+2,100
| +1% | +$4.81K | ﹤0.01% | 3101 |
|
|
2022
Q4 | $292K | Sell |
142,300
-7,500
| -5% | -$16.6K | ﹤0.01% | 3230 |
|
|
2022
Q3 | $325K | Sell |
149,800
-11,300
| -7% | -$26.2K | ﹤0.01% | 3177 |
|
|
2022
Q2 | $408K | Buy |
161,100
+11,400
| +8% | +$29.7K | ﹤0.01% | 3278 |
|
|
2022
Q1 | $400K | Buy |
149,700
+7,400
| +5% | +$18.1K | ﹤0.01% | 3323 |
|
|
2021
Q4 | $381K | Buy |
142,300
+13,300
| +10% | +$44.5K | ﹤0.01% | 3225 |
|
|
2021
Q3 | $489K | Sell |
129,000
-6,100
| -5% | -$23.2K | ﹤0.01% | 2901 |
|
|
2021
Q2 | $574K | Sell |
135,100
-22,100
| -14% | -$95.2K | ﹤0.01% | 2911 |
|
|
2021
Q1 | $794K | Sell |
157,200
-47,100
| -23% | -$274K | ﹤0.01% | 2711 |
|
|
2020
Q4 | $1.07M | Sell |
204,300
-5,500
| -3% | -$31.5K | ﹤0.01% | 2466 |
|
|
2020
Q3 | $1.1M | Sell |
209,800
-13,883
| -6% | -$80.1K | ﹤0.01% | 2466 |
|
|
2020
Q2 | $1.21M | Sell |
223,683
-21,217
| -9% | -$112K | ﹤0.01% | 2452 |
|
|
2020
Q1 | $911K | Buy |
244,900
+208,400
| +571% | +$1.08M | ﹤0.01% | 2472 |
|
|
2019
Q4 | $246K | Buy |
+36,500
| New | +$274K | ﹤0.01% | 3135 |
|
|
2018
Q2 | – | Sell |
-65,200
| Closed | -$666K | – | 3429 |
|
|
2018
Q1 | $666K | Sell |
65,200
-14,300
| -18% | -$142K | ﹤0.01% | 2813 |
|
|
2017
Q4 | $514K | Buy |
79,500
+43,900
| +123% | +$291K | ﹤0.01% | 2884 |
|
|
2017
Q3 | $227K | Buy |
35,600
+24,600
| +224% | +$131K | ﹤0.01% | 2971 |
|
|
2017
Q2 | $58K | Buy |
+11,000
| New | +$61.7K | ﹤0.01% | 3115 |
|
|
2016
Q3 | – | Sell |
-34,500
| Closed | -$260K | – | 3440 |
|
|
2016
Q2 | $260K | Sell |
34,500
-65,600
| -66% | -$474K | ﹤0.01% | 2980 |
|
|
2016
Q1 | $735K | Buy |
100,100
+1,900
| +2% | +$9.41K | ﹤0.01% | 2720 |
|
|
2015
Q4 | $349K | Sell |
98,200
-4,900
| -5% | -$15.6K | ﹤0.01% | 2846 |
|
|
2015
Q3 | $290K | Sell |
103,100
-12,600
| -11% | -$43K | ﹤0.01% | 2776 |
|
|
2015
Q2 | $457K | Buy |
115,700
+4,900
| +4% | +$19.4K | ﹤0.01% | 2750 |
|
|
2015
Q1 | $388K | Sell |
110,800
-5,000
| -4% | -$17.8K | ﹤0.01% | 2686 |
|
|
2014
Q4 | $352K | Buy |
115,800
+66,400
| +134% | +$225K | ﹤0.01% | 2528 |
|
|
2014
Q3 | $148K | Buy |
+49,400
| New | +$113K | ﹤0.01% | 2596 |
|
Other funds holding MNOV
EWM
VCM
VFT
Renaissance Technologies's MNOV Position: Q1 2026 in Review
Renaissance Technologies reduced its MediciNova (MNOV) stake by 3.5% in Q1 2026, selling an estimated $10.5K and leaving 189,900 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #2848.
Renaissance Technologies first reported a position in MNOV in Q3 2014 and has held it in 38 quarters since. The position peaked at $1.21M in Q2 2020. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.
- Renaissance Technologies held 189,900 shares of MediciNova worth $260K as of Q1 2026.
- Renaissance Technologies sold 6,900 MediciNova shares in Q1 2026, an estimated $10.5K.
- MediciNova made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2848 holding.
- Renaissance Technologies first reported a position in MediciNova in Q3 2014 and has held it in 38 quarters since.
- Renaissance Technologies's MediciNova position peaked at $1.21M in Q2 2020.
- 30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.